Overview

Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the performance of Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) in patients with Alzheimer's disease (AD).
Phase:
Phase 4
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Choline
Donepezil